| scholarly article | Q13442814 |
| P2093 | author name string | Yu Han | |
| Zeng B Zhu | |||
| Maciej S Lesniak | |||
| Ilya V Ulasov | |||
| Matthew A Tyler | |||
| Sophy Zheng | |||
| P2860 | cites work | Genetically modified adenoviruses against gliomas: from bench to bedside | Q35860372 |
| Why do we need new gene therapy viral vectors? Characteristics, limitations and future perspectives of viral vector transduction | Q35972119 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Adenoviridae | Q193447 |
| P304 | page(s) | 151-160 | |
| P577 | publication date | 2007-03-01 | |
| P1433 | published in | Journal of Gene Medicine | Q15746377 |
| P1476 | title | Fiber-knob modifications enhance adenoviral tropism and gene transfer in malignant glioma | |
| P478 | volume | 9 |
| Q64376825 | A Dendritic Cell-Targeted Adenoviral Vector Facilitates Adaptive Immune Response Against Human Glioma Antigen (CMV-IE) and Prolongs Survival in a Human Glioma Tumor Model |
| Q35658592 | A Genetically Modified Adenoviral Vector with a Phage Display-Derived Peptide Incorporated into Fiber Fibritin Chimera Prolongs Survival in Experimental Glioma |
| Q37475446 | A chimeric adenovirus with an Ad 3 fiber knob modification augments glioma virotherapy. |
| Q36609123 | A novel adenoviral vector labeled with superparamagnetic iron oxide nanoparticles for real-time tracking of viral delivery |
| Q36367252 | A novel single-chain antibody redirects adenovirus to IL13Rα2-expressing brain tumors |
| Q36220624 | Ad3-hTERT-E1A, a fully serotype 3 oncolytic adenovirus, in patients with chemotherapy refractory cancer |
| Q37409025 | Adenoviral vector-based strategies for cancer therapy |
| Q37223846 | Adenoviral virotherapy for malignant brain tumors |
| Q33994011 | Adenovirus receptors and their implications in gene delivery |
| Q37132217 | Biodistribution of an oncolytic adenovirus after intracranial injection in permissive animals: a comparative study of Syrian hamsters and cotton rats |
| Q35095013 | CRAdRGDflt-IL24 virotherapy in combination with chemotherapy of experimental glioma. |
| Q37147851 | Combination of adenoviral virotherapy and temozolomide chemotherapy eradicates malignant glioma through autophagic and apoptotic cell death in vivo |
| Q35029126 | Directing systemic oncolytic viral delivery to tumors via carrier cells |
| Q33862517 | Enhanced transduction and replication of RGD-fiber modified adenovirus in primary T cells |
| Q35880459 | Gene therapy trials for the treatment of high-grade gliomas |
| Q47141309 | Hitting the nail on the head: combining oncolytic adenovirus-mediated virotherapy and immunomodulation for the treatment of glioma |
| Q34667746 | Mutation of the fiber shaft heparan sulphate binding site of a 5/3 chimeric adenovirus reduces liver tropism |
| Q39023173 | Neural stem cell-mediated delivery of oncolytic adenovirus. |
| Q39067827 | Novel oncolytic viral therapies in patients with thoracic malignancies |
| Q35077747 | Oncolytic adenoviruses: A thorny path to glioma cure |
| Q64245487 | Rodents Versus Pig Model for Assessing the Performance of Serotype Chimeric Ad5/3 Oncolytic Adenoviruses |
| Q36904198 | Single dose GLP toxicity and biodistribution study of a conditionally replicative adenovirus vector, CRAd-S-pk7, administered by intracerebral injection to Syrian hamsters |
| Q37466041 | Stem cells as delivery vehicles for oncolytic adenoviral virotherapy. |
| Q35551921 | Tamoxifen improves cytopathic effect of oncolytic adenovirus in primary glioblastoma cells mediated through autophagy |
| Q34183436 | Treatment of cancer patients with a serotype 5/3 chimeric oncolytic adenovirus expressing GMCSF. |
| Q39561803 | Truncating the i-leader open reading frame enhances release of human adenovirus type 5 in glioma cells |
Search more.